PubMed COVID-19 Clinical Care
48211 - 48220 of 49233 results found
Treatment of post-intensive care tracheal stenosis after previous covid-19 pneumonia
Description
CONCLUSION: Patients after invasive mechanical ventilation for COVID-19 pneumonia are at high risk of cicatricial tracheal stenosis and require follow-up. Circular tracheal resection ensures early rehabilitation and favorable functional results
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register
Description
CONCLUSION: Patients with uncontrolled asthma and high disease burden, including increased asthma medication intensity, should be identified as risk patients for severe COVID-19. Furthermore, current smoking is strongly associated with COVID-19 death
Reported exposure trends among healthcare personnel COVID-19 cases, USA, March 2020-March 2021
Description
CONCLUSIONS: Many reported HCP cases experienced occupational COVID-19 exposures, particularly during periods of higher community COVID-19 incidence.
Stability analysis and optimal control of COVID-19 with quarantine and media awareness
Description
In this paper, an improved COVID-19 model is given to investigate the influence of treatment and media awareness, and a non-linear saturated treatment function is introduced in the model to lay stress on the limited medical conditions. Equilibrium
Virtual teaching in the COVID era: Providing surgical core trainee teaching via online webinars and videoconferencing
Description
CONCLUSION: A novel, highly successful teaching programme was developed in Northern Ireland to meet the training needs of CSTs resulting in a sustained change to training. Virtual surgical teaching can be as effective as face-to-face didactic
Favipiravir in SARS-CoV-2 infection: Is it Worthwhile?
Description
Favipiravir is a potential antiviral drug undergoing clinical trials to manage various viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Favipiravir possesses antiviral properties against RNA viruses, including
Assessment of specific human antibodies against recombinant SARS-CoV-2 receptor binding domain by rapid in-house ELISA
Description
CONCLUSIONS: In conclusion, specific human antibodies against SARS-CoV-2 spike protein were detected by rapid in-house ELISA in sera of human COVID-19-infected patients. The availability of this in-house ELISA protocol would be valuable for various
Persistence of mental health deterioration among people living alone during the COVID-19 pandemic: a periodically-repeated longitudinal study
Description
BackgroundThis longitudinal study aimed to investigate how psychological distress levels changed from early to middle phases of the new coronavirus (COVID-19) pandemic depending on the living arrangements of individuals.MethodAn internet-based
